FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutical composition, which contains ZD6474 or its pharmaceutically acceptable salt, fragile thinner and second thinner, which is practically insoluble and possesses compression plasticity. Fragile thinner represents calcium hydrophosphate, and second thinner, which is practically insoluble and possesses compression plasticity, represents microcrystalline cellulose.
EFFECT: good bioavailability for active substance.
5 cl, 7 tbl, 5 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| WATER-DISPERSIBLE DESLORATADINE PILL AND METHOD FOR ITS MANUFACTURE | 2015 |
|
RU2631619C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND AN SGLT-2 INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2770043C1 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A DPP-IV INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2770775C1 |
| IMMEDIATE-RELEASE SOLID DOSAGE FORM OF HYDROXYCHLOROQUINE AND METHOD FOR PRODUCING IT | 2014 |
|
RU2580656C1 |
| SOLID PHARMACEUTICAL FORM OF IMMEDIATELY RELEASING ZAFIRLUKAST AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2619213C1 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING DESLORATADINE (VERSIONS) | 2013 |
|
RU2537169C1 |
| PHARMACEUTICAL ANTIFUNGAL COMPOSITION BASED ON A CHLOROPHENYLBUTANEDIONE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2707286C1 |
| METHOD FOR PREPARING TERIFLUNOMIDE TABLETS | 2013 |
|
RU2536258C1 |
